Menu
GOVPH
  • Home
  • HTA Governance
    • Universal Health Care Act
    • Administrative Order on HTA
    • Philippine HTA Process Guide
    • Philippine HTA Methods Guide
    • Philippine HTA Code of Conduct
  • About Us
    • Mission/Vision
    • Health Technology Assessment Council (HTAC)
    • Health Technology Assessment Unit (HTAU)
    • HTA Philippines Annual Report
      • 2020 Annual Report
    • Road to HTA Institutionalization
    • External Partners
  • Issuances
  • Assessments
  • Evidence Briefs
  • FAQs
  • Get Involved with Us
    • Contact Us
    • Careers
    • Call for Interested Parties
    • Topic Nomination
  • AUXILIARY MENU
  • GOVPH
  • Home
  • HTA Governance
    • Universal Health Care Act
    • Administrative Order on HTA
    • Philippine HTA Process Guide
    • Philippine HTA Methods Guide
    • Philippine HTA Code of Conduct
  • About Us
    • Mission/Vision
    • Health Technology Assessment Council (HTAC)
    • Health Technology Assessment Unit (HTAU)
    • HTA Philippines Annual Report
      • 2020 Annual Report
    • Road to HTA Institutionalization
    • External Partners
  • Issuances
  • Assessments
  • Evidence Briefs
  • FAQs
  • Get Involved with Us
    • Contact Us
    • Careers
    • Call for Interested Parties
    • Topic Nomination

Preliminary Recommendation

PRELIMINARY RECOMMENDATION ON Dolutegravir (DTG)

Preliminary recommendation on Tenofovir/Lamivudine/Dolutegravir (TLD)

306931
Users Today : 1133
This Month : 38045
Total Users : 306931
Your IP Address : 34.239.160.86
Philippine Standard Time:
✕

Philippine Society of Microbiology and Infectious Diseases (PSMID) releases Philippine COVID-19 Living Recommendations

View the document on their website: https://www.psmid.org/philippine-covid-19-living-recommendations/